Regenerative Medicine Center of Orthopedics and Other Degenerative Diseases located in Glenview, IL
It was a great experience. Already feeling relief from pain.
"Thanks to GIOSTAR, I feel that darkness is not an option for me now."
"The improvement which we saw in our child was unbelievable."
"Their extensive research and their expert team helped me to get back on my feet."
"GIOSTAR was no less than a miracle to me."
"No complaints whatsoever. Thanks for giving me a new life and a healthy one."
"I thank god that I listened to my friend’s advice and came to GIOSTAR."
"After undergoing Stem Cell Therapy at Giostar, I can feel my knees gaining strength.
GIOSTAR Chicago is supported with scientific know-how by Global Institute of Stem Cell Therapy and Research (GIOSTAR), who is the pioneer in regenerative medicine and stem cell-based technologies. GIOSTAR Chicago is an independently run facility from GIOSTAR. GIOSTAR has been involved in the field of stem cell research for almost two decades in the U.S.A. They have provided treatments to thousands of patients using their advanced protocols outside of U.S.A. Headquartered in San Diego, California, the Institute is an established leader in what is widely regarded as the most highly advanced field of science.
GIOSTAR is comprised of a world-renowned international group of researchers, doctors and scientists in the fields of stem cell biology, cancer, and gene therapy. The team has won numerous awards, conducted pioneering studies, and published extensive research in leading medical journals. Further, GIOSTAR Chairman and Co-founder Dr. Anand Srivastava has helped develop stem cell research programs for prestigious institutions in the U.S.A., such as the University of California San Diego (UCSD), Salk Research Institute, San Diego, California, University of California Irvine (UCI), Burnham Institute of Medical Research, San Diego, California and University of California Los Angeles (UCLA).
GIOSTAR is the leader in developing the most advanced stem cell-based technologies, supported by prominent scientists and physicians trained at leading universities in U.S.A. and abroad. As a leader in the field of regenerative medicine, GIOSTAR’s vision is to develop and provide safe, effective, affordable, researched based therapies to those suffering from degenerative or genetic diseases around the globe.
About Our Practice
Patients at GIOSTAR Chicago in Glenview, Illinois, benefit from and can depend on safe, extensively researched regenerative cell-based therapies designed to rejuvenate and treat several musculoskeletal injuries and degenerative conditions.
GIOSTAR Chicago offers cutting-edge regenerative medicine techniques and protocols that have been extensively researched and developed by our leading scientists.
How do we stand out from local area centers?
GIOSTAR CHICAGO leverages GIOSTAR’s customized, proprietary treatment protocols to treat each and every one of our patients. Our protocols were developed based on research grants, endowment, and private funding. Regenerative medicine is a highly complex field of medicine that requires years and years of extensive ongoing research. Most local centers do not fully grasp the nuances and intricacies of this field. They do not have teams of dedicated research scientists conducting ongoing US-based clinical studies to enable their centers to continue providing the most advanced science to their patients.
The GIOSTAR Chicago center does not take a “one size fits all” approach to medicine. GIOSTAR was formed a decade ago to do intensive research, and strives for higher quality control and excellence. Our scientists hail from University of California, San Diego (UCSD), Salk Institute, University of California Irvine (UCI), University of California Los Angeles (UCLA), and other prestigious USA universities. Armed with extensive training, they deliver cutting edge, research-based treatment protocols to GIOSTAR Chicago and beyond. This rigorous approach enables us to stay abreast of the latest techniques and advancements in the ever-evolving field of regenerative medicine. In parallel with patient care, our teams of highly-skilled research scientists devote countless hours each day to make history by advancing the field of medicine and changing people’s lives for the better.
Dr. Anand Srivastava is a proud recipient of the United States House of Representatives Certificate of Recognition for “Best Of Business” in recognition for co-founding GlOSTAR
Dr. Anand Srivastava cloned 23 genes while working for the government of Japan in 1998. In 1997 and 1998, he was awarded the Japan International Science and Technology Exchange Center (JISTEC) Award, a highly prestigious international scientific award. He is the only leading scientist to have earned this accolade twice. Dr. Srivastava also earned the Who’s Who award in 2005, 2010, 2014, and 2018.
Working at UC Irvine, Dr. Srivastava and the team of researchers conducted the FIRST FDA Approved Human Clinical Trial with the Christopher & Dana Reeve Foundation for spinal cord injury, which started in 2007.
You now have direct access to a higher level of expertise for your stem cell therapy.
Prior to his passing in 2018, renowned physicist Stephen Hawking met with Mr. Deven Patel, CEO of GIOSTAR, to learn about how stem cell research could help treat Amyotrophic Lateral Sclerosis (ALS), the neurological disease he’d suffered from for most of his life.
Click below to read more!
THE SAFEST AND MOST EFFECTIVE STEM CELL THERAPY IN 7 COUNTRIES
GIOSTAR OFFERS YOU ACCESS TO GOVERNMENT AND UNIVERSITY LEVEL RESEARCH THAT BEGAN IN 1998
Dr. Anand is credited with many of the fundamental creations that have made the entire industry of modern stem cell science possible. Governments worldwide rely on his expertise and guidance to determine policy, best practices and safety procedures.
AWARDS & RECOGNITION
Dr. Anand and GIOSTAR have been recognized by several governments worldwide, Japan, India, Poland, Saudi Arabia, and Mexico, for our work. Further, the team has received the prestigious Best In Business award by the United States Government for research and service for treatment of debilitating diseases.
PUBLICATIONS & JOURNALS
Dr. Anand’s discoveries, innovations and publications are the most utilized by doctors and scientists in the field of stem cells. There are many journals dedicated to his work, he is a world renowned speaker and is the reviewer of several journals in the industry.
While working at UC Irvine, Dr. Anand and the team of researchers conducted the FIRST FDA Approved Human Clinical Trial with Christopher and Dana Reeves Foundation for spinal cord injury in 2007. You now have direct access to this level of expertise for your stem cell therapy.
Avoid the scams.
What patients should watch out for when selecting their treatment providers
GIOSTAR CEO, Mr. Deven Patel succeeded in bringing his vision: “to deliver the most advanced and expensive science to the most impoverished masses of India” to fruition. It is with this advancement, that GIOSTAR is changing the face of regenerative medicine today around the globe.